ML165

CAS No. 1355454-05-5

ML165( RUC-2 | ML 165 )

Catalog No. M11454 CAS No. 1355454-05-5

A high-affinity, selective platelet integrin αIIbβ3 receptor antagonist with IC50 of 96 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    ML165
  • Note
    Research use only, not for human use.
  • Brief Description
    A high-affinity, selective platelet integrin αIIbβ3 receptor antagonist with IC50 of 96 nM.
  • Description
    A high-affinity, selective platelet integrin αIIbβ3 receptor antagonist with IC50 of 96 nM; specifically inhibits ligand binding by a novel mechanism, leading to loss of the MIDAS metal ion while producing only minor changes in the conformation of β3.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    RUC-2 | ML 165
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Integrin
  • Recptor
    Integrin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1355454-05-5
  • Formula Weight
    385.446
  • Molecular Formula
    C17H19N7O2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C1=CC=C(C=C1)F)NC2=CC(=CC(=N2)NC3=NC=CN=C3)C4=CN(N=C4)C.C(=CC(=O)O)C(=O)O
  • Chemical Name
    2-amino-N-(3-(5-oxo-7-(piperazin-1-yl)-5H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-2-yl)phenyl)acetamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zhu J, et al. Sci Transl Med. 2012 Mar 14;4(125):125ra32. 2. Jiang JK, et al. Bioorg Med Chem Lett. 2014 Feb 15;24(4):1148-53.
molnova catalog
related products
  • P11

    Potent antagonist of the integrin αvβ3-vitronectin interaction (IC50 = 25.72 nM). Blocks proliferation and induces apoptosis in HUVECs; antiangiogenic.

  • Elarofiban TFA

    Elarofiban TFA (RWJ-53308 TFA) is a novel and orally active and selective GPIIb/IIIa antagonist for the study of cardiovascular disease.

  • GLPG-0187

    GLPG-0187 (GLPG0187) is a highly potent, broad spectrum integrin receptor antagonist.